Morgan Advanced Materials plc (LON:MGAM)
225.50
-1.50 (-0.66%)
Aug 6, 2025, 4:35 PM BST
Revance Therapeutics Market Cap
Morgan Advanced Materials has a market cap or net worth of 628.75 million as of August 6, 2025. Its market cap has decreased by -30.30% in one year.
Market Cap
628.75M
Enterprise Value
937.65M
Revenue
1.10B
Ranking
n/a
PE Ratio
12.89
Stock Price
$225.50
Market Cap Chart
Since January 31, 1992, Morgan Advanced Materials's market cap has increased from 565.91M to 628.75M, an increase of 11.10%. That is a compound annual growth rate of 0.31%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 6, 2025 | 628.75M | -18.31% |
Dec 31, 2024 | 769.66M | -4.31% |
Dec 29, 2023 | 804.30M | -9.95% |
Dec 30, 2022 | 893.21M | -12.43% |
Dec 31, 2021 | 1.02B | 15.44% |
Dec 31, 2020 | 883.64M | -1.99% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Rolls-Royce Holdings | 91.69B |
RELX PLC | 71.41B |
BAE Systems | 54.86B |
Experian | 35.92B |
Ashtead Group | 21.41B |
International Consolidated Airlines Group | 17.52B |
Halma | 12.29B |
Rentokil Initial | 8.91B |